Literature DB >> 11793160

Lack of association between CYP1A1 polymorphism and Parkinson's disease in a Chinese population.

D K Y Chan1, G D Mellick, D D Buchanan, W T Hung, P W Ng, J Woo, R Kay.   

Abstract

Apart from very few families who have a direct cause from genetic mutation, causes of most Parkinson's disease (PD) remain unclear. Many allelic association studies on polymorphism of different candidate genes have been studied. Although these association studies do not imply a causal relationship, it does warrant further studies to elucidate the pathophysiologic significance. CYP1A1 polymorphisms have been reported to be associated with PD in a Japanese population sample. Since CYP1A1 transforms aromatic hydrocarbons into products that may be neurotoxic and perhaps lead to PD, we therefore undertook a study to look at the possible association of CYP1A1 polymorphism and PD in a Chinese population. Contrary to the Japanese result, we did not find any statistically significant difference between the PD group and the control group in our study with a bigger sample size.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793160     DOI: 10.1007/s702-002-8234-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  3 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  Sexual dimorphism in xenobiotic genetic variants-mediated risk for Parkinson's disease.

Authors:  Nadella Kumudini; Addepally Uma; Shaik Mohammad Naushad; Rukmini Mridula; Rupam Borgohain; Vijay Kumar Kutala
Journal:  Neurol Sci       Date:  2014-01-04       Impact factor: 3.307

3.  Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson's Disease.

Authors:  Hui-Hui Fan; Bao-Qing Li; Ke-Yun Wu; Hai-Dan Yan; Meng-Jie Gu; Xing-Hao Yao; Hao-Jia Dong; Xiong Zhang; Jian-Hong Zhu
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.